<a href="https://laohu8.com/S/CATX">Perspective Therapeutics</a> Updates Executive Compensation and Change-in-Control Terms
Perspective Therapeutics Inc. has entered into amended and restated employment agreements with Chief Executive Officer Johan (Thijs) Spoor, Chief Accounting Officer Jonathan Hunt, and Chief Medical Officer Dr. Markus Puhlmann. The updated agreements set annual base salaries at $680,000 for Mr. Spoor, $451,500 for Mr. Hunt, and $516,700 for Dr. Puhlmann. In the event of termination without cause or resignation for good reason during a period beginning three months before and ending 12 months after a change in control, executives will receive severance pay equal to 12 months of salary (18 months for Mr. Spoor), a pro-rated annual bonus, an additional annual bonus payment (1.5 times for Mr. Spoor), and up to 12 months of COBRA health coverage (18 months for Mr. Spoor). The agreements also provide for accelerated vesting of equity awards under certain conditions related to a change in control.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perspective Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-262636), on November 03, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。